Alnustone: A review of its sources, pharmacology, and pharmacokinetics ‏‏

Zahra Salari,Maryam Alavi,Hojjat Rezaii-zadeh,Abdelhakim Bouyahya,Ammar Alfergah,Sahar Afsari Sardari,Ehsan Amiri-Ardekani
DOI: https://doi.org/10.2174/0118761429252459231115060139
2024-01-26
Current Molecular Pharmacology
Abstract:Abstract: Alnustone (4(E)-,6(E)-1,7-Diphenyl-hepta-4,6-dien-3-one) is a non-phenolic natural diarylheptanoid, which was first isolated and identified from the male flower of Alnus pendula (Betulaceae). It can also be isolated from Curcuma xanthorrhiza Roxb (Zingiberaceae) rhizomes and Alpinia katsumadai Hayata (Zingiberaceae) seeds. It was first synthesized through a five-step process from β-phenyl propionyl chloride. In later years, new methods for synthesizing Alnustone were designed and performed with different yields. Due to the various therapeutic effects exhibited by alnustone like other diarylheptanoids, its biological activities such as antioxidant, antibacterial, and anti-inflammatory properties have been the subject of many studies. This article has reviewed different aspects of this valuable natural compound, including its natural and synthetic sources, therapeutic effects, and pharmacokinetics as a potential future therapeutic agent.
biochemistry & molecular biology,pharmacology & pharmacy
What problem does this paper attempt to address?